$MTEM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Molecular Templates, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Molecular Templates, Inc.. Get notifications about new insider transactions in Molecular Templates, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 21 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.08 | 40,852 | 329,941 | 9,542,621 | 9.5 M to 9.5 M (+0.43 %) |
Apr 19 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.62 | 150,000 | 1,292,655 | 9,501,769 | 9.4 M to 9.5 M (+1.60 %) |
Apr 15 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.37 | 150,000 | 1,256,040 | 9,351,769 | 9.2 M to 9.4 M (+1.63 %) |
Apr 15 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 7.81 | 100,000 | 780,970 | 9,201,769 | 9.1 M to 9.2 M (+1.10 %) |
Apr 13 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.02 | 50,000 | 400,830 | 9,101,769 | 9.1 M to 9.1 M (+0.55 %) |
Apr 13 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.23 | 235,664 | 1,939,633 | 9,051,769 | 8.8 M to 9.1 M (+2.67 %) |
Apr 09 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.22 | 300,000 | 2,466,660 | 8,816,105 | 8.5 M to 8.8 M (+3.52 %) |
Apr 09 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.24 | 200,000 | 1,648,160 | 8,516,105 | 8.3 M to 8.5 M (+2.40 %) |
Apr 07 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 9.44 | 200,000 | 1,887,100 | 8,316,105 | 8.1 M to 8.3 M (+2.46 %) |
Mar 31 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.45 | 80,000 | 915,848 | 8,116,105 | 8 M to 8.1 M (+1.00 %) |
Feb 25 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.48 | 75,000 | 860,835 | 8,036,105 | 8 M to 8 M (+0.94 %) |
Feb 25 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.29 | 235,004 | 2,653,031 | 7,961,105 | 7.7 M to 8 M (+3.04 %) |
Feb 19 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 12.65 | 1,185,770 | 14,999,991 | 7,726,101 | 6.5 M to 7.7 M (+18.13 %) |
Feb 17 2021 | MTEM | Molecular Template ... | Cutler Adam D. | See remarks | Option Exercise | A | 14.05 | 125,000 | 1,756,250 | 125,000 | |
Feb 17 2021 | MTEM | Molecular Template ... | Waltzman Roger J. | See remarks | Option Exercise | A | 14.05 | 125,000 | 1,756,250 | 125,000 | |
Feb 01 2021 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 11.94 | 80,000 | 955,000 | 6,460,331 | 6.4 M to 6.5 M (+1.25 %) |
Dec 11 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.18 | 170,000 | 1,391,416 | 6,380,331 | 6.2 M to 6.4 M (+2.74 %) |
Dec 11 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.39 | 150,000 | 1,258,425 | 6,210,331 | 6.1 M to 6.2 M (+2.48 %) |
Dec 11 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.62 | 125,000 | 1,077,600 | 6,060,331 | 5.9 M to 6.1 M (+2.11 %) |
Nov 12 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 9.16 | 80,000 | 732,472 | 5,935,331 | 5.9 M to 5.9 M (+1.37 %) |
Nov 12 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 9.05 | 80,000 | 724,144 | 5,855,331 | 5.8 M to 5.9 M (+1.39 %) |
Nov 04 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 8.83 | 80,000 | 706,312 | 5,229,996 | 5.1 M to 5.2 M (+1.55 %) |
Nov 04 2020 | MTEM | Molecular Template ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 9.40 | 80,000 | 751,688 | 5,149,996 | 5.1 M to 5.1 M (+1.58 %) |
Sep 18 2020 | MTEM | Molecular Template ... | LALANDE KEVIN M. | Director | Sell | S | 13.05 | 500,000 | 6,525,000 | 6,097,298 | 6.6 M to 6.1 M (-7.58 %) |
Sep 18 2020 | MTEM | Molecular Template ... | SHV Management Services, LLC | 10% Owner | Sell | S | 13.05 | 500,000 | 6,525,000 | 6,097,298 | 6.6 M to 6.1 M (-7.58 %) |
Sep 01 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | S | 10.75 | 1,049 | 11,273 | 0 | 1 K to 0 (-100.00 %) |
Sep 01 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | S | 10.75 | 2,447 | 26,296 | 0 | 2.4 K to 0 (-100.00 %) |
Jun 01 2020 | MTEM | Molecular Template ... | HOFFMANN DAVE | Director | Option Exercise | A | 15.43 | 15,000 | 231,450 | 15,000 | |
Jun 01 2020 | MTEM | Molecular Template ... | Hirsch David | Director | Option Exercise | A | 15.43 | 15,000 | 231,450 | 15,000 | |
Jun 01 2020 | MTEM | Molecular Template ... | Morenstein Scott D | Director | Option Exercise | A | 15.43 | 15,000 | 231,450 | 15,000 | |
Jun 01 2020 | MTEM | Molecular Template ... | Sanders Corazon (Corsee) D. | Director | Option Exercise | A | 15.43 | 15,000 | 231,450 | 15,000 | |
May 28 2020 | MTEM | Molecular Template ... | Hirsch David | Director | Buy | J | 0.00 | 1,649 | 0 | 1,649 | 0 to 1.6 K |
May 28 2020 | MTEM | Molecular Template ... | Hirsch David | Director | Sell | J | 0.00 | 1,000,000 | 0 | 3,199,035 | 4.2 M to 3.2 M (-23.81 %) |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 1,049 | 0 | 1,049 | 0 to 1 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 2,447 | 0 | 2,447 | 0 to 2.4 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | J | 0.00 | 3,495 | 0 | 3,495 | 0 to 3.5 K |
May 28 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 3,199,035 | 4.2 M to 3.2 M (-23.81 %) |
May 22 2020 | MTEM | Molecular Template ... | LALANDE KEVIN M. | Director | Sell | S | 16.51 | 300,000 | 4,953,000 | 6,597,298 | 6.9 M to 6.6 M (-4.35 %) |
May 22 2020 | MTEM | Molecular Template ... | SHV Management Services, LLC | 10% Owner | Sell | S | 16.51 | 300,000 | 4,953,000 | 6,597,298 | 6.9 M to 6.6 M (-4.35 %) |
May 04 2020 | MTEM | Molecular Template ... | LALANDE KEVIN M. | Director | Sell | J | 0.00 | 1,000,000 | 0 | 6,897,298 | 7.9 M to 6.9 M (-12.66 %) |
May 04 2020 | MTEM | Molecular Template ... | SHV Management Services, LLC | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 6,897,298 | 7.9 M to 6.9 M (-12.66 %) |
Feb 18 2020 | MTEM | Molecular Template ... | Waltzman Roger J. | Chief Medical Offic ... | Option Exercise | A | 14.50 | 120,000 | 1,740,000 | 120,000 | |
Feb 18 2020 | MTEM | Molecular Template ... | Cutler Adam D. | See remarks | Option Exercise | A | 14.50 | 150,000 | 2,175,000 | 150,000 | |
Feb 18 2020 | MTEM | Molecular Template ... | Poma Eric E | See remarks | Option Exercise | A | 14.50 | 312,500 | 4,531,250 | 312,500 | |
Feb 18 2020 | MTEM | Molecular Template ... | Kim Jason S. | See remarks | Option Exercise | A | 14.50 | 150,000 | 2,175,000 | 150,000 | |
Jan 03 2020 | MTEM | Molecular Template ... | Kim Jason S. | See Remarks | Option Exercise | M | 0.42 | 54,136 | 22,737 | 0 | |
Jan 03 2020 | MTEM | Molecular Template ... | Kim Jason S. | See Remarks | Option Exercise | M | 0.42 | 54,136 | 22,737 | 0 | |
Jan 03 2020 | MTEM | Molecular Template ... | Kim Jason S. | See Remarks | Buy | M | 0.42 | 54,136 | 22,737 | 54,136 | 0 to 54.1 K |
Jan 03 2020 | MTEM | Molecular Template ... | Kim Jason S. | See Remarks | Buy | M | 0.42 | 54,136 | 22,737 | 54,136 | 0 to 54.1 K |
Dec 20 2019 | MTEM | Molecular Template ... | Sanders Corazon (Corsee) D. | Director | Option Exercise | A | 12.69 | 25,000 | 317,250 | 25,000 | |
Nov 27 2019 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 8.00 | 937,000 | 7,496,000 | 4,198,535 | 3.3 M to 4.2 M (+28.73 %) |
Nov 27 2019 | MTEM | Molecular Template ... | Hirsch David | Director | Buy | P | 8.00 | 937,000 | 7,496,000 | 4,198,535 | 3.3 M to 4.2 M (+28.73 %) |
Nov 27 2019 | MTEM | Molecular Template ... | Hirsch David | Director | Buy | P | 8.00 | 937,000 | 7,496,000 | 4,198,535 | 3.3 M to 4.2 M (+28.73 %) |
Nov 25 2019 | MTEM | Molecular Template ... | Morenstein Scott D | Director | Buy | P | 8.00 | 468,750 | 3,750,000 | 2,052,991 | 1.6 M to 2.1 M (+29.59 %) |
May 30 2019 | MTEM | Molecular Template ... | LALANDE KEVIN M. | Director | Option Exercise | A | 8.21 | 15,000 | 123,150 | 15,000 | |
May 30 2019 | MTEM | Molecular Template ... | HOFFMANN DAVE | Director | Option Exercise | A | 8.21 | 15,000 | 123,150 | 15,000 | |
May 30 2019 | MTEM | Molecular Template ... | Morenstein Scott D | Director | Option Exercise | A | 8.21 | 15,000 | 123,150 | 15,000 | |
May 30 2019 | MTEM | Molecular Template ... | SELICK HAROLD E | Director | Option Exercise | A | 8.21 | 15,000 | 123,150 | 15,000 | |
May 30 2019 | MTEM | Molecular Template ... | Hirsch David | Director | Option Exercise | A | 8.21 | 15,000 | 123,150 | 15,000 | |
Feb 21 2019 | MTEM | Molecular Template ... | Waltzman Roger J. | SVP, Chief Medical ... | Option Exercise | A | 4.80 | 175,000 | 840,000 | 175,000 | |
Feb 20 2019 | MTEM | Molecular Template ... | Cutler Adam D. | See remarks | Option Exercise | A | 4.66 | 92,000 | 428,720 | 92,000 | |
Feb 20 2019 | MTEM | Molecular Template ... | Poma Eric E | See remarks | Option Exercise | A | 4.66 | 250,000 | 1,165,000 | 250,000 | |
Feb 20 2019 | MTEM | Molecular Template ... | Kim Jason S. | See Remarks | Option Exercise | A | 4.66 | 130,000 | 605,800 | 130,000 | |
Dec 28 2018 | MTEM | Molecular Template ... | CDK ASSOCIATES, L.L.C. | Director | Buy | P | 3.45 | 25,000 | 86,250 | 1,584,241 | 1.6 M to 1.6 M (+1.60 %) |
Nov 29 2018 | MTEM | Molecular Template ... | Poma Eric E | See Remarks | Option Exercise | M | 0.71 | 86,951 | 61,735 | 3,563 | |
Nov 29 2018 | MTEM | Molecular Template ... | Poma Eric E | See Remarks | Option Exercise | M | 0.42 | 152,945 | 64,237 | 0 | |
Nov 29 2018 | MTEM | Molecular Template ... | Poma Eric E | See Remarks | Buy | M | 0.71 | 86,951 | 61,735 | 239,896 | 152.9 K to 239.9 K (+56.85 %) |
Nov 29 2018 | MTEM | Molecular Template ... | Poma Eric E | See Remarks | Buy | M | 0.42 | 152,945 | 64,237 | 152,945 | 0 to 152.9 K |
Sep 27 2018 | MTEM | Molecular Template ... | Morenstein Scott D | Director | Buy | P | 5.50 | 545,454 | 2,999,997 | 1,559,241 | 1 M to 1.6 M (+53.80 %) |
Sep 25 2018 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 5.50 | 365,000 | 2,007,500 | 3,261,535 | 2.9 M to 3.3 M (+12.60 %) |
Sep 25 2018 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 5.50 | 365,000 | 2,007,500 | 3,261,535 | 2.9 M to 3.3 M (+12.60 %) |
Sep 25 2018 | MTEM | Molecular Template ... | Hirsch David | Director | Buy | P | 5.50 | 365,000 | 2,007,500 | 3,261,535 | 2.9 M to 3.3 M (+12.60 %) |
Jun 04 2018 | MTEM | Molecular Template ... | Kim Jason S. | See Remarks | Option Exercise | A | 6.31 | 100,000 | 631,000 | 100,000 | |
Jun 04 2018 | MTEM | Molecular Template ... | LALANDE KEVIN M. | Director | Option Exercise | A | 6.31 | 15,000 | 94,650 | 15,000 | |
Jun 04 2018 | MTEM | Molecular Template ... | HOFFMANN DAVE | Director | Option Exercise | A | 6.31 | 15,000 | 94,650 | 15,000 | |
Jun 04 2018 | MTEM | Molecular Template ... | SELICK HAROLD E | Director | Option Exercise | A | 6.31 | 15,000 | 94,650 | 15,000 | |
Nov 15 2017 | THLD | Molecular Template ... | Cutler Adam D. | CFO and Treasurer | Option Exercise | A | 8.05 | 225,000 | 1,811,250 | 225,000 | |
Oct 11 2017 | THLD | Molecular Template ... | Hirsch David | Director | Option Exercise | A | 9.40 | 25,000 | 235,000 | 25,000 | |
Oct 11 2017 | THLD | Molecular Template ... | LALANDE KEVIN M. | Director | Option Exercise | A | 9.40 | 25,000 | 235,000 | 25,000 | |
Oct 11 2017 | THLD | Molecular Template ... | Poma Eric E | See Remarks | Option Exercise | A | 9.40 | 275,000 | 2,585,000 | 275,000 | |
Oct 11 2017 | THLD | Molecular Template ... | Kim Jason S. | See Remarks | Option Exercise | A | 9.40 | 137,500 | 1,292,500 | 137,500 | |
Oct 11 2017 | THLD | Molecular Template ... | Morenstein Scott D | Director | Option Exercise | A | 9.40 | 25,000 | 235,000 | 25,000 | |
Oct 11 2017 | THLD | Molecular Template ... | HOFFMANN DAVE | Director | Option Exercise | A | 9.40 | 25,000 | 235,000 | 25,000 | |
Oct 11 2017 | THLD | Molecular Template ... | SELICK HAROLD E | Director | Option Exercise | A | 9.40 | 25,000 | 235,000 | 25,000 | |
Jun 02 2017 | THLD | THRESHOLD PHARMACE ... | BIRD JEFFREY W | Director | Buy | P | 0.57 | 37,626 | 21,349 | 377,782 | 340.2 K to 377.8 K (+11.06 %) |
Jun 02 2017 | THLD | THRESHOLD PHARMACE ... | BIRD JEFFREY W | Director | Buy | P | 0.57 | 473,077 | 268,424 | 3,940,573 | 3.5 M to 3.9 M (+13.64 %) |
Jun 02 2017 | THLD | THRESHOLD PHARMACE ... | BIRD JEFFREY W | Director | Sell | J | 0.00 | 630,770 | 0 | 3,467,496 | 4.1 M to 3.5 M (-15.39 %) |
Jun 28 2016 | THLD | THRESHOLD PHARMACE ... | BIRD JEFFREY W | Director | Option Exercise | A | 0.38 | 35,000 | 13,300 | 35,000 | |
Jun 28 2016 | THLD | THRESHOLD PHARMACE ... | PARKER GEORGE GC | Director | Option Exercise | A | 0.38 | 35,000 | 13,300 | 35,000 | |
Jun 28 2016 | THLD | THRESHOLD PHARMACE ... | PARKER GEORGE GC | Director | Option Exercise | A | 0.38 | 35,000 | 13,300 | 35,000 | |
Jun 28 2016 | THLD | THRESHOLD PHARMACE ... | JAEGER WILFRED E | Director | Option Exercise | A | 0.38 | 35,000 | 13,300 | 35,000 | |
Jun 28 2016 | THLD | THRESHOLD PHARMACE ... | HOFFMANN DAVE | Director | Option Exercise | A | 0.38 | 35,000 | 13,300 | 35,000 | |
Jun 28 2016 | THLD | THRESHOLD PHARMACE ... | Parkinson David Ross | Director | Option Exercise | A | 0.38 | 35,000 | 13,300 | 35,000 | |
Jun 28 2016 | THLD | THRESHOLD PHARMACE ... | COZADD BRUCE C | Director | Option Exercise | A | 0.38 | 35,000 | 13,300 | 35,000 | |
Mar 17 2016 | THLD | THRESHOLD PHARMACE ... | PARKER GEORGE GC | Director | Option Exercise | M | 1.30 | 2,500 | 3,250 | 0 | |
Mar 17 2016 | THLD | THRESHOLD PHARMACE ... | PARKER GEORGE GC | Director | Buy | M | 1.30 | 2,500 | 3,250 | 8,572 | 6.1 K to 8.6 K (+41.17 %) |
Mar 15 2016 | THLD | THRESHOLD PHARMACE ... | SELICK HAROLD E | Chief Executive Off ... | Option Exercise | A | 0.53 | 800,000 | 424,000 | 800,000 | |
Mar 15 2016 | THLD | THRESHOLD PHARMACE ... | Pearce Tillman | Chief Medical Offic ... | Option Exercise | A | 0.55 | 200,000 | 110,000 | 200,000 | |
Mar 15 2016 | THLD | THRESHOLD PHARMACE ... | Kroll Stewart M. | Chief Operating Off ... | Option Exercise | A | 0.55 | 300,000 | 165,000 | 300,000 | |
Mar 15 2016 | THLD | THRESHOLD PHARMACE ... | Fernandes Joel A | Senior Vice Preside ... | Option Exercise | A | 0.55 | 200,000 | 110,000 | 200,000 | |
Mar 01 2016 | THLD | THRESHOLD PHARMACE ... | BIRD JEFFREY W | Director | Buy | J | 0.00 | 96,010 | 0 | 340,156 | 244.1 K to 340.2 K (+39.32 %) |
Mar 01 2016 | THLD | THRESHOLD PHARMACE ... | BIRD JEFFREY W | Director | Sell | J | 0.00 | 617,132 | 0 | 4,098,266 | 4.7 M to 4.1 M (-13.09 %) |
Mar 01 2016 | THLD | THRESHOLD PHARMACE ... | JAEGER WILFRED E | Director | Sell | J | 0.00 | 27,500 | 0 | 52,500 | 80 K to 52.5 K (-34.37 %) |
Apr 29 2016 | THLD | THRESHOLD PHARMACE ... | Fernandes Joel A | Senior Vice Preside ... | Buy | P | 3.96 | 3,562 | 14,106 | 28,120 | 24.6 K to 28.1 K (+14.50 %) |
Jul 06 2015 | THLD | THRESHOLD PHARMACE ... | BIRD JEFFREY W | Director | Option Exercise | A | 3.87 | 20,000 | 77,400 | 20,000 | |
Jul 06 2015 | THLD | THRESHOLD PHARMACE ... | PARKER GEORGE GC | Director | Option Exercise | A | 3.87 | 20,000 | 77,400 | 20,000 | |
Jul 06 2015 | THLD | THRESHOLD PHARMACE ... | HOFFMANN DAVE | Director | Option Exercise | A | 3.87 | 20,000 | 77,400 | 20,000 | |
Jul 06 2015 | THLD | THRESHOLD PHARMACE ... | COZADD BRUCE C | Director | Option Exercise | A | 3.87 | 20,000 | 77,400 | 20,000 | |
Jul 06 2015 | THLD | THRESHOLD PHARMACE ... | Parkinson David Ross | Director | Option Exercise | A | 3.87 | 20,000 | 77,400 | 20,000 | |
Jul 06 2015 | THLD | THRESHOLD PHARMACE ... | JAEGER WILFRED E | Director | Option Exercise | A | 3.87 | 20,000 | 77,400 | 20,000 | |
Mar 02 2015 | THLD | THRESHOLD PHARMACE ... | Kroll Stewart M. | Senior Vice Preside ... | Option Exercise | A | 4.43 | 100,000 | 443,000 | 100,000 | |
Mar 02 2015 | THLD | THRESHOLD PHARMACE ... | Pearce Tillman | Chief Medical Offic ... | Option Exercise | A | 4.43 | 160,000 | 708,800 | 160,000 | |
Mar 02 2015 | THLD | THRESHOLD PHARMACE ... | Fernandes Joel A | VP, Finance & Contr ... | Option Exercise | A | 4.43 | 70,000 | 310,100 | 70,000 | |
Mar 02 2015 | THLD | THRESHOLD PHARMACE ... | SELICK HAROLD E | Chief Executive Off ... | Option Exercise | A | 4.43 | 400,000 | 1,772,000 | 400,000 | |
Mar 02 2015 | THLD | THRESHOLD PHARMACE ... | Davar Nipun | Vice President | Option Exercise | A | 4.43 | 100,000 | 443,000 | 100,000 | |
Mar 02 2015 | THLD | THRESHOLD PHARMACE ... | SIMON ROBERT L | Senior Vice Preside ... | Option Exercise | A | 4.43 | 100,000 | 443,000 | 100,000 | |
Feb 20 2015 | THLD | THRESHOLD PHARMACE ... | JAEGER WILFRED E | Director | Option Exercise | P | 10.86 | 25,000 | 271,500 | 25,000 | |
Feb 20 2015 | THLD | THRESHOLD PHARMACE ... | JAEGER WILFRED E | Director | Buy | P | 3.75 | 25,000 | 93,625 | 80,000 | 55 K to 80 K (+45.45 %) |
Oct 14 2014 | THLD | THRESHOLD PHARMACE ... | Davar Nipun | Vice President | Buy | P | 2.99 | 3,000 | 8,955 | 3,000 | 0 to 3 K |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Option Exercise | X | 2.05 | 2,452 | 5,027 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Option Exercise | X | 2.05 | 26,509 | 54,343 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Option Exercise | X | 2.05 | 417,050 | 854,953 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Sell | S | 3.77 | 1,332 | 5,024 | 89,275 | 90.6 K to 89.3 K (-1.47 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Buy | X | 2.05 | 2,452 | 5,027 | 90,607 | 88.2 K to 90.6 K (+2.78 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Sell | S | 3.77 | 14,407 | 54,343 | 112,480 | 126.9 K to 112.5 K (-11.35 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Buy | X | 2.05 | 26,509 | 54,343 | 126,887 | 100.4 K to 126.9 K (+26.41 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Sell | S | 3.77 | 226,657 | 854,950 | 4,715,398 | 4.9 M to 4.7 M (-4.59 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | YOUNGER WILLIAM H JR | 10% Owner | Buy | X | 2.05 | 417,050 | 854,953 | 4,942,055 | 4.5 M to 4.9 M (+9.22 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | WHITE JAMES N | 10% Owner | Option Exercise | X | 2.05 | 23,704 | 48,593 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | WHITE JAMES N | 10% Owner | Option Exercise | X | 2.05 | 417,050 | 854,953 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | WHITE JAMES N | 10% Owner | Sell | S | 3.77 | 12,881 | 48,587 | 264,669 | 277.6 K to 264.7 K (-4.64 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | WHITE JAMES N | 10% Owner | Buy | X | 2.05 | 23,704 | 48,593 | 277,550 | 253.8 K to 277.6 K (+9.34 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | WHITE JAMES N | 10% Owner | Sell | S | 3.77 | 226,657 | 854,950 | 4,715,398 | 4.9 M to 4.7 M (-4.59 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | WHITE JAMES N | 10% Owner | Buy | X | 2.05 | 417,050 | 854,953 | 4,942,055 | 4.5 M to 4.9 M (+9.22 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Option Exercise | X | 2.05 | 797 | 1,634 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Option Exercise | X | 2.05 | 3,798 | 7,786 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Option Exercise | X | 2.05 | 417,050 | 854,953 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Sell | S | 3.77 | 433 | 1,633 | 11,312 | 11.7 K to 11.3 K (-3.69 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Buy | X | 2.05 | 797 | 1,634 | 11,745 | 10.9 K to 11.7 K (+7.28 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Sell | S | 3.77 | 2,064 | 7,785 | 39,795 | 41.9 K to 39.8 K (-4.93 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Buy | X | 2.05 | 3,798 | 7,786 | 41,859 | 38.1 K to 41.9 K (+9.98 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Sell | S | 3.77 | 226,657 | 854,950 | 4,715,398 | 4.9 M to 4.7 M (-4.59 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SWEET DAVID E | 10% Owner | Buy | X | 2.05 | 417,050 | 854,953 | 4,942,055 | 4.5 M to 4.9 M (+9.22 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | Speiser Michael L | 10% Owner | Option Exercise | X | 2.05 | 1,051 | 2,155 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | Speiser Michael L | 10% Owner | Option Exercise | X | 2.05 | 417,050 | 854,953 | 0 | |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | Speiser Michael L | 10% Owner | Sell | S | 3.77 | 571 | 2,154 | 11,884 | 12.5 K to 11.9 K (-4.58 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | Speiser Michael L | 10% Owner | Buy | X | 2.05 | 1,051 | 2,155 | 12,455 | 11.4 K to 12.5 K (+9.22 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | Speiser Michael L | 10% Owner | Sell | S | 3.77 | 226,657 | 854,950 | 4,715,398 | 4.9 M to 4.7 M (-4.59 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | Speiser Michael L | 10% Owner | Buy | X | 2.05 | 417,050 | 854,953 | 4,942,055 | 4.5 M to 4.9 M (+9.22 %) |
Oct 03 2014 | THLD | THRESHOLD PHARMACE ... | SHEEHAN ANDREW T | 10% Owner | Option Exercise | X | 2.05 | 6,802 | 13,944 | 0 |